“…Additionally, no clinical study has used the alveolar bone tissue from T2DM patients to investigate the expression of bone-related markers isolated from other events, such as the repair of critical-sized bone defects and other healing models. Additionally, bone biopsies are rarely undertaken in humans and most investigations analysing diabetic bone tissue have been performed in animal studies, 22,24,37,38 or have evaluated circulating bone-related markers in humans. 18,19,39 This investigation elucidated possible molecular mechanisms through which T2DM may interfere with bone tissue repair around implants under hyperglycaemic conditions.…”